Rare diseases affect one in 17 people in the UK, but a Government initiative designed to improve their quality of life will ...

Sanofi (NASDAQ:SNY) announced Tuesday that rilzabrutinib, an oral therapy for an autoimmune blood disorder called immune thrombocytopenia (ITP), reached the primary endpoint in a Phase 3 trial.

The long-held view that ITP is predominantly caused ... patients with co-existent vascular disease. In contrast, worsening thrombocytopenia and severe bleeding has been described in some ...

Patients across the UK with chronic immune thrombocytopenia (ITP) now have another treatment ... Grifols' Tavlesse for adults with the rare blood disorder. Tavlesse (fostamatinib) can now be ...

Bone marrow biopsies are not a routinely recommended part of the work up and diagnosis of ITP in accordance to multiple international guidelines, but a new study re-examines this approach.

Anthony Heard from Lower Earley was diagnosed with Immune Thrombocytopenia (ITP) 19 year's ago highlights the significant mental health challenges that come with the condition to this day. The ...

Doptelet (avatrombopag) – an oral thrombopoietin receptor agonist – has been cleared to boost depleted levels of platelets in the blood of patients with ITP, an autoimmune clotting disorder ...

Plasma medicine helped her to have a family after she developed a blood disorder. Danielle had immune thrombocytopenic purpura (ITP) – her immune system destroyed her platelets, the cell ...